Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04284150Unknown
Randomised trial of dexmedetomidine in supraventricular tachycardia (SVT), sponsored by First People's Hospital of Lianyungang City. Primary endpoints: Dexmedetomidine treatment of supraventricular tachycardia at 6 months and Midazolam treatment of supraventricular tachycardia at 6 months. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04284150.